Development of novel bis-pyrazole derivatives as antitumor agents with potent apoptosis induction effects and DNA damage

被引:53
|
作者
Dai, Hong [1 ,2 ]
Ge, Shushan [1 ,2 ]
Guo, Jing [2 ,3 ]
Chen, Shi [2 ,3 ]
Huang, Meiling [2 ]
Yang, Jiaying [2 ]
Sun, Siyu [1 ]
Ling, Yong [1 ,2 ,3 ]
Shi, Yujun [1 ]
机构
[1] Nantong Univ, Coll Chem & Chem Engn, Nantong 226019, Peoples R China
[2] Nantong Univ, Sch Pharm, Nantong 226001, Peoples R China
[3] Nantong Univ, Jiangsu Prov Key Lab Inflammat & Mol Drug Target, Nantong 226001, Peoples R China
关键词
Synthesis; Antitumor agent; Bis-pyrazole derivatives; Apoptosis; DNA damage; FLUORINATED TEBUFENPYRAD ANALOGS; BIOLOGICAL EVALUATION; OXIME DERIVATIVES; ANTICANCER ACTIVITY; MOLECULAR DOCKING; DESIGN; INHIBITORS; MOIETY; FENPYROXIMATE; SKELETON;
D O I
10.1016/j.ejmech.2017.11.098
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of bis-pyrazole derivatives were designed and synthesized, and their antitumor effects in vitro and in vivo were investigated. Several compounds displayed good antiproliferative activity with IC50 values in low-micromolar range against three human cancer cell lines in vitro, superior to 5-FU. The most potent compound 10M selectively inhibited human hepatocellular carcinoma cells but not non-tumor liver cell proliferation in vitro, and significantly triggered SMMC-7721 cell apoptosis by cleavage of both PARP and caspase-3 in a concentration-dependent manner. Further study revealed that the potent activity in the cell growth inhibition and apoptosis induction effects of 10M were related to DNA damage and activation of the p53 signaling pathway. Moreover, 10M showed low acute toxicity to mice and significant growth inhibition of the hepatoma tumor in vivo. (C) 2017 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1066 / 1076
页数:11
相关论文
共 50 条
  • [31] Development of novel phenoxy-diketopiperazine-type plinabulin derivatives as potent antimicrotubule agents based on the co-crystal structure
    Ding, Zhongpeng
    Ma, Mingxu
    Zhong, Changjiang
    Wang, Shixiao
    Fu, Zhangyu
    Hou, Yingwei
    Liu, Yuqian
    Zhong, Lili
    Chu, Yanyan
    Li, Feng
    Song, Cai
    Wang, Yuxi
    Yang, Jinliang
    Li, Wenbao
    BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (01)
  • [32] Synthesis of novel indole derivatives as promising DNA-binding agents and evaluation of antitumor and antitopoisomerase I activities
    Lafayette, Elizabeth Almeida
    Vitalino de Almeida, Sinara Monica
    Cavalcanti Santos, Renata Virginia
    de Oliveira, Jamerson Ferreira
    da Cruz Amorim, Cezar Augusto
    Ferreira da Silva, Rosali Maria
    da Rocha Pitta, Maira Galdino
    Pitta, Ivan da Rocha
    de Moura, Ricardo Olimpio
    de Carvalho Junior, Luiz Bezerra
    Barreto de Melo Rego, Moacyr Jesus
    Alves de Lima, Maria do Carmo
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 136 : 511 - 522
  • [33] The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo
    Cui, Ying-Jie
    Ma, Chen-Chen
    Zhang, Cheng-Mei
    Tang, Long-Qian
    Liu, Zhao-Peng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 187
  • [34] Synthesis of novel, DNA binding heterocyclic dehydroabietylamine derivatives as potential antiproliferative and apoptosis-inducing agents
    Zhao, Fengyi
    Sun, Xu
    Lu, Wen
    Xu, Li
    Shi, Jiuzhou
    Yang, Shilong
    Zhou, Mengyi
    Su, Fan
    Lin, Feng
    Cao, Fuliang
    DRUG DELIVERY, 2020, 27 (01) : 216 - 227
  • [35] Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with DNA damage and apoptosis inducing abilities
    Liu, Ji
    Wang, Tingting
    Wang, Xinyang
    Luo, Lin
    Guo, Jing
    Peng, Yanfu
    Xu, Qibing
    Miao, Jiefei
    Zhang, Yanan
    Ling, Yong
    MEDCHEMCOMM, 2017, 8 (06) : 1213 - 1219
  • [36] Novel β-carboline-based indole-4,7-quinone derivatives as NAD(P)H: Quinone-oxidoreductase-1 inhibitor with potent antitumor activities by inducing reactive oxygen species, apoptosis, and DNA damage
    Guo, Yibing
    Xu, Liancheng
    Ling, Changchun
    Yang, Tao
    Zheng, Wenjie
    Lv, Jin
    Guo, Qingsong
    Chen, Bohua
    CHEMICAL BIOLOGY & DRUG DESIGN, 2020, 96 (06) : 1433 - 1446
  • [37] Design, synthesis and biological evaluation of novel benzo- and tetrahydrobenzo-[h]quinoline derivatives as potential DNA-intercalating antitumor agents
    Jafari, Fatemeh
    Baghayi, Hedyeh
    Lavaee, Parirokh
    Hadizadeh, Farzin
    Soltani, Fatemeh
    Moallemzadeh, Hamideh
    Mirzaei, Salimeh
    Aboutorabzadeh, Sayyed Mohammad
    Ghodsi, Razieh
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 164 : 292 - 303
  • [38] Synthesis, mechanisms of action, and toxicity of novel aminophosphonates derivatives conjugated irinotecan in vitro and in vivo as potent antitumor agents
    Huang, Xiaochao
    Wang, Meng
    You, Qinghong
    Kong, Jing
    Zhang, Haijiang
    Yu, Chunhao
    Wang, Yanming
    Wang, Hengshan
    Huang, Rizhen
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 189
  • [39] Design, synthesis and biological evaluation of novel plumbagin derivatives as potent antitumor agents with STAT3 inhibition
    Li, Na
    Ou, Jinfeng
    Bao, Na
    Chen, Cheng
    Shi, Zhixian
    Chen, Li
    Sun, Jianbo
    BIOORGANIC CHEMISTRY, 2020, 104
  • [40] Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents
    Azad, Iqbal
    Nasibullah, Malik
    Khan, Tahmeena
    Hassan, Firoj
    Akhter, Yusuf
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2018, 81 : 211 - 228